Title	Publication Date	Language	Citations
CORRELATION BETWEEN SARCOPENIA AND HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS	2022/01/01	English
SERUM DETERMINATION OF MMP-2 AND MMP-9 ACCORDING TO THE PATTERN OF ALCOHOL CONSUMPTION AND IN ALCOHOLIC HEPATIC DISEASE	2022/01/01	English
DETERMINATION OF LEUKOCYTE PROFILE IN CHRONIC ALCOHOL CONSUMPTION	2022/01/01	English
IMPACT OF REFRACTORY ASCITES ON THE SURVIVAL OF PATIENTS WITH CIRRHOSIS	2022/01/01	English
GLUCOGENOSIS AS A CAUSE OF INTRAHEPATIC CHOLESTASIS	2022/01/01	English
CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AS A PROMOTER IN THE DEVELOPMENT OF FIBROSIS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS	2022/01/01	English
NEOBUXBAMIA TETETZO AS A CAUSE OF DRUG-INDUCED LIVER INJURY	2022/01/01	English
STUDY OF CONCORDANCE BETWEEN THE DEGREE OF LIVER FIBROSIS ESTIMATED THROUGH APRI AND FIB-4 BIOCHEMICAL SCORES, AND ELASTORESONANCE IN PATIENTS WITH AUTOIMMUNE HEPATITIS	2022/01/01	English
PORTA VEIN THROMBOSIS (PVT) IN CIRRHOTIC PATIENTS PRE AND DURING THE PANDEMIC BY SARS-COV2	2022/01/01	English
HEPATOCELLULAR CARCINOMA IN VERACRUZ: A SURVEILLANCE COMPARISON BETWEEN TREATMENTS	2022/01/01	English
INITIAL EVALUATION OF KIDNEY FUNCTION IN PATIENTS WITH LIVER CIRRHOSIS OF CEIHET, HIDALGO	2022/01/01	English
HEPATOCELLULAR CARCINOMA: CLINICAL AND EPIDEMIOLOGICAL FEATURES IN VERACRUZ	2022/01/01	English
IMPACT OF RISK FACTORS IN THE SCRUTINY AND DIAGNOSIS OF HEPATITIS C	2022/01/01	English
TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE	2022/01/01	English
COMPARISON OF SEROLOGICAL MODELS OF LIVER FIBROSIS AGAINST TRANSIENT ELASTOGRAPHY BY FIBROSCAN® IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE	2022/01/01	English
IGFBP-1 TO 7 AS BIOMARKERS IN STAGES OF LIVER FIBROSIS DURING VIRAL HEPATITIS C	2022/01/01	English
HGF AND PROTECTIVE ROLL IN THE INTESTINAL COLLATERAL DAMAGE BY Α-NAFTILISOTIOCIANATO- INDUCE CHOLESTASIS.	2022/01/01	English
Global real-world evidence of sofosbuvir/velpatasvir (SOF/VEL) as a highly effective treatment in underserved patient populations because of mental health disorders, incarceration or homelessness	2022/01/01	English
HEPATIC STEATOSIS IN CYSTIC FIBROSIS. APROPOS OF A CASE	2022/01/01	English
HEPATIC MANIFESTATIONS OF INFECTIOUS DISEASES. PRESENTATION OF CLINICAL CASE	2022/01/01	English
CLEAR CELL HEPATOCELLULAR CARCINOMA, A CASE REPORT	2022/01/01	English
EDITORIAL BOARD	2022/01/01	English
The growing need to monitor the liver function after SARS-CoV-2 infection in the Mexican population with obesity	2022/05/01	English
Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?	2022/05/01	English
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant	2017/05/01	English
Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients	2017/11/01	English
Analysis of the MELD Score Impact in the Outcome of Endovascular Portal Vein Reconstruction	2017/11/01	English
Reply	2017/11/01	English
Could TIPS be Applied in All Kinds of Portal Vein Thrombosis: We are not Sure!	2017/11/01	English
Ironing out Steatohepatitis	2017/01/01	English